Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PEGASUS: Predicting Esophageal Cancer Borders Using PET-Imaging
NCT06408116Phase 2Recruiting
- Sponsor
- Heidelberg University Hospital
- Start
- Mar 2024
- Primary completion
- Jan 2028
- Countries
- 1
01
Overview
Phase 2, open-label trial in esophageal cancer (3 arms), sponsored by Heidelberg University Hospital. Primary endpoint: Tumor expansion. Started Mar 2024; status: recruiting.
02
Conditions
esophageal cancer
Beyond the preview
Go deeper on NCT06408116.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06408116.